Key facts
- NORTHSTRIVE FUND II LP filed SCHEDULE 13G for Bluejay Diagnostics, Inc. Common Stock, $0.0001 par value per share.
- Disclosed ownership: 5%.
- Date of event: 05 Feb 2026.
NORTHSTRIVE FUND II LP - 05 Feb 2026 SCHEDULE 13G Report for Bluejay Diagnostics, Inc. Common Stock, $0.0001 par value per share
- Shares outstanding
- 708,583 shares
- Disclosed shares
- 35,500 shares
- Ownership percentage
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Feb 2026, 21:43:08 UTC
- Event date
- 05 Feb 2026
- Next filing
- 11 Mar 2026
- SEC filing
- View on sec.gov
Subject security
Ownership signal
SEC evidence
Key filing fact
NORTHSTRIVE FUND II LP disclosed 5% ownership in Bluejay Diagnostics, Inc. Common Stock, $0.0001 par value per share on 05 Feb 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2026, 21:43.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Northstrive Fund II LP | 1.6% | 11,000 | 0 | 11,000 | /s/ Braeden Lichti | Braeden Lichti, Manager | |
| Braeden Lichti | 5% | 35,500 | 24,500 | 11,000 | /s/ Braeden Lichti | Braeden Lichti |
CIK / CUSIP context first